Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases

التفاصيل البيبلوغرافية
العنوان: Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases
المؤلفون: Daniel Geßner, Mirjeta Berisha, Torben Esser, Enrico Schalk
المصدر: Annals of Hematology.
بيانات النشر: Springer Science and Business Media LLC, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Hematology, General Medicine
الوصف: Tigecycline has been used to treat patients with febrile neutropenia (FN). This study aims to analyse the effectiveness of tigecycline as salvage treatment of FN. Patients records from 09/2004 to 04/2019 were reviewed. Cases were eligible if fever persisted/recurred (p/r-FN) after 3 days of second-line treatment with a carbapenem, and were divided into three groups: switch to tigecycline (TGC group), switch to other antibiotics (OAB group), and no switch (W&W group). The primary endpoint was response rate (defervescence for ≥ 7 days or at least until discharge); the key secondary endpoint was 30-day mortality rate. Two hundred cases from 176 patients (median 59 years; 53.5% men) treated were included, mostly acute myeloid leukaemias (61.0%). 45.5% of cases were in the TGC group (in combination with an anti-pseudomonal antibiotic, mostly ceftazidime [95.6%]); 35.5% were in the OAB and 19.0% in the W&W group. There was no significant difference in response rates (TGC, 73.6%; OAB, 62.0%; W&W, 78.9%; p = 0.12) or 30-day mortality rates (TGC, 7.7%; OAB, 7.0%; W&W, 5.3%; p = 0.94). Tigecycline plus an anti-pseudomonal antibiotic does not improve response or 30-day mortality rate compared to other antibiotics in patients with p/r-FN. Also, in some cases, no switch in antibiotics may be necessary at all.
تدمد: 1432-0584
0939-5555
DOI: 10.1007/s00277-023-05222-5
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5f151348fd19fa038ccbb05c4ab33326
https://doi.org/10.1007/s00277-023-05222-5
Rights: OPEN
رقم الانضمام: edsair.doi...........5f151348fd19fa038ccbb05c4ab33326
قاعدة البيانات: OpenAIRE
الوصف
تدمد:14320584
09395555
DOI:10.1007/s00277-023-05222-5